Cummins Inc. (NYSE:CMI) shares moved down -0.63% in last trading session and ended the day at $96.59. CMI Gross Margin is 25.90% and its has a return on assets of 8.90%. Cummins Inc. (NYSE:CMI) quarterly performance is 0.64%.
On 9 February, Cummins Inc. (NYSE:CMI) announced that it has entered into an accelerated share repurchase (ASR) agreement with Goldman, Sachs & Co. (GS &Co.) to repurchase $500 million of Cummins’ common stock. Today’s ASR is part of Cummins’ previously announced share repurchase plans authorized by the Board of Directors.
Interxion Holding NV (NYSE:INXN) ended the last trading day at $31.00. Company weekly volatility is calculated as 1.99% and price to cash ratio as 39.43. Interxion Holding NV (NYSE:INXN) showed a weekly performance of 5.87%.
Interxion Holding N.V. (NYSE:INXN), a leading European provider of cloud-and carrier-neutral colocation data centre services, will release its fourth quarter and full year 2015 results on Wednesday, 2 March 2016, and will host a conference call at 8:30 a.m. ET (1:30 p.m. GMT, 2:30 p.m. CET) to discuss the results.
On 19 February, Donaldson Company, Inc. (NYSE:DCI) shares moved down -0.51% and was closed at $29.27. DCI EPS growth in last 5 year was 7.30%. Donaldson Company, Inc. (NYSE:DCI) year to date (YTD) performance is 2.73%.
Donaldson Company, Inc. (NYSE:DCI) will webcast its fiscal 2016 second quarter earnings conference call at 9:00 a.m. CT on Tuesday, March 1, 2016.
Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) shares moved down -5.45% in last trading session and ended the day at $2.08. ATNM has a return on assets of -100.80%. Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) quarterly performance is -5.45%.
On 16 February, Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) announced that key clinical and business development personnel will be attending the annual meetings of the Center for International Blood & Marrow Transplant Research (CIBMTR) and the American Society of Blood and Marrow Transplantation (ASBMT), referred to as the BMT Tandem Meetings.
Raptor Pharmaceuticals Corp. (NASDAQ:RPTP) caters to the Healthcare space. It has a net profit margin of -77.20% and weekly performance is 2.86%. On the last day of trading company shares ended up at $3.96.
Raptor Pharmaceutical Corp. (NASDAQ:RPTP) announced that the company will release fourth quarter and full year 2015 financial results on Thursday, February 25, 2016, after market close. Management will conduct a conference call and live audio webcast at 4:30 p.m. ET (1:30 p.m. PT) that day to discuss the financial results and provide a corporate update.
Leave a Reply